GOG-3119 MK-2870-033 TroFuse-033 sac-TMT + Pembro as 1L Maintenance in pMMr Endometrial cancer

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
A Phase 3 Randomized, Open-label, Multicenter Study to Compare the Efficacy and safety of Sacituzumab Tirumotecan in Combination with Pembrolizumab Versus Pembrolizumab Alone as First-line Maintenance Treatment in Participants with Mismatch Repair Proficient Endometrial Cancer (TroFuse-033/GOG-3119/ENGOT-en29)
Principal Investigator
Headshot of Angeles Alvarez Secord
Professor of Obstetrics and Gynecology
Protocol Number
IRB: PRO00118136
NCT: NCT06952504
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL
Participate